Literature DB >> 25459462

Systemic therapies for diabetic retinopathy: the accord eye study.

Robert N Frank1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25459462     DOI： 10.1016/j.ophtha.2014.08.019

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  7 in total

Review 1.  The role of dyslipidemia in diabetic retinopathy.

Authors:  Sandra S Hammer; Julia V Busik
Journal:  Vision Res       Date:  2017-05-26       Impact factor: 1.886

Review 2.  Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.

Authors:  Harshini Chakravarthy; Vasudharani Devanathan
Journal:  J Mol Neurosci       Date:  2018-10-06       Impact factor: 3.444

Review 3.  Diabetic retinopathy and systemic factors.

Authors:  Robert N Frank
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

4.  Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy.

Authors:  Sunil Mamtora; Teresa Sandinha; Peter E Carey; David H W Steel
Journal:  Ophthalmol Ther       Date:  2016-11-17

5.  Assessing the Clinical Utility of Point of Care HbA1c in the Ophthalmology Outpatient Setting.

Authors:  Sunil Mamtora; Panayiotis Maghsoudlou; Hani Hasan; Wenrui Zhang; Mohamed El-Ashry
Journal:  Clin Ophthalmol       Date:  2021-01-07

6.  Prevalence and Associated Factors of Diabetic Retinopathy among Type 2 Diabetes Mellitus Patients in Brunei Darussalam: A Cross-sectional Study.

Authors:  Sajid Adhi Raja; Vui Heng Chong; Noor A Rahman; Lilabi M P Shakir; Joe Knights
Journal:  Korean J Ophthalmol       Date:  2021-11-08

7.  Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.

Authors: 
Journal:  Diabetes Care       Date:  2016-06-11       Impact factor: 19.112
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.